| Hubbell, Jeffrey A. (Anokion 201701 Chairman + CSO + Academic Founder + Prof at Univ Chicago + before at EPFL) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Anokion (Group) |
Switzerland |
| Huber, Andreas (Bayern (Govt) 201310 Senior Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Huber, Caroline (Tecan 201211 Senior Market Manager) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Huber, Christian (Univ Salzburg 201310 Professor + Head of CD Lab for Biosimilar Characterization) |
Professor |
University of Salzburg |
Austria |
| Huber, Christoph (CI3 Cluster 201307 Board Member of CI3 e.V.) |
n. a. |
Ci3 Cluster (Cluster für Individualisierte ImmunIntervention e. V.) |
Germany |
| Huber, Fritz (LipoFIT GmbH 201204 Managing Director + Co-founder) |
Managing Director |
Numares (Group) |
Germany |
| Huber, Hans (Biomay 201505 COO) |
Chief Operating Officer (COO) |
Biomay AG |
Austria |
| Huber, Jutta (Eurofins 201405 Managing Director Eurofins Genomics GmbH before MWG Biotech) |
Managing Director |
Eurofins (Group) |
Germany |
| Huber, Lukas (Medical Univ Innsbruck 201211 Professor + Director of the Biocenter) |
Professor |
Medical University Innsbruck (MUI) |
Austria |
| Huber, Mario (PharmaMar 201612– Managing Director of PharmaMar Austria before Quintiles) |
Managing Director |
PharmaMar (AT) |
Austria |
| Huber, Martin (Quantapore 201406 CEO + Founder before Ion Torrent) |
Chief Executive Officer (CEO) |
Quantapore Inc. |
United States (USA) |
| Huber, Robert (Univ Duisburg-Essen 201004 Professor ZMB before Max Planck Institute for Biochemistry, Nobel Laureate) |
Professor |
University of Duisburg-Essen |
Germany |
| Huber, Roman (Bayern Kapital 200612 Managing Director) |
Managing Director |
Bavaria (govt region) |
Germany |
| Huber, Walter (Merck 200601) |
n. a. |
Merck (DE) (Group) |
Germany |
| Huber-Saffer, Peter (Chiesi 201410 Business Development Manager at Chiesi GmbH) |
Business Development Manager / Strategy Manager |
Chiesi (Group) |
Germany |
| Huc, Jean-Francois (BioAmber 201207 CEO) |
Chief Executive Officer (CEO) |
BioAmber (Group) |
United States (USA) |
| Huchler, Roland (InnoCyte GmbH 201211 Managing Director + Founder) |
Managing Director |
InnoCyte GmbH |
Germany |
| Hudson, Paul (Novartis 201605– Executive Committee Member + Head Pharmaceuticals Business Unit before AstraZeneca) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Huebscher, Karen (Solvias 201403– CEO before Novartis) |
Chief Executive Officer (CEO) |
Solvias (Group) |
Switzerland |
| Huels, Christoph (Protagen 200704 CEO) |
Chief Executive Officer (CEO) |
Oncimmune (Group) |
Germany |
| Huelso, Gerd (Bruker 201310 Managing Director at Bruker Daltonik GmbH) |
Managing Director |
Bruker Corporation (Group) |
Germany |
| Huenges, Martin (Maiwald Patentanwalts GmbH 200809 Munich) |
n. a. |
Maiwald Patentanwalts GmbH (Munich) |
Germany |
| Hufnagel, Peter (Bruker 200712 Bruker Daltonik GmbH Project Manager ProteinScape) |
Product Manager (personnel) |
Bruker Corporation (Group) |
Germany |
| Hug, Peter (Roche Pharma Partnering 200511) |
n. a. |
Roche (Group) |
Switzerland |
| Hughes, Owen (MPM Capitap 201710 Managing Director + Cullinan Oncology 201710– CEO before Intarcia + 16y at Wall Street) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
| Huhle, Doreen (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Huland, Edith (Immunservice GmbH 201205 Managing Director) |
Managing Director |
Immunservice GmbH |
Germany |
| Hulot, Thierry (Merck (DE) 201310– Head of Global Manufacturing + Supply at Merck Serono joined Merck 1995) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
Germany |
| Humbey, Olivier (Accovion 201412– Country Director France) |
Regional manager |
Clinipace (Group) |
France |
| Humer, Franz B. (Roche –2014 non-exec Chairman before CEO) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Humpf, Hans-Ulrich (Univ Münster 201305 Professor) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Humphries, Paul (Flextronics 201806 President High-reliability Solutions) |
n. a. |
Flextronics (d/b/a Flex) (Group) |
Singapore |
| Hundle, Bhupinder (Eucodis 200910– VP Marketing and Sales) |
Sales Manager / Marketing Manager |
Eucodis Bioscience (Group) |
Austria |
| Hung, David T. (Roviant Sciences 201704– CEO of Axovant before Medivation 201604 CEO) |
Chief Executive Officer (CEO) |
Roivant (Group) |
United States (USA) |
| Hunkapiller, Michael (Mike) (Pacific Biosciences 201201– CEO before Alloy Ventures + ABI 1983–2004 President) |
Chief Executive Officer (CEO) |
Pacific Biosciences of California Inc. (PacBio) (Nasdaq: PACB) |
United States (USA) |
| Hunkapiller, Tim (Disocovery Biosciences + Univ of Washington + Caltech) |
Researcher (university / research institute) |
Discovery Biosciences Corporation |
United States (USA) |
| Hunneyball, Ian M. |
n. a. |
Evotec (Group) |
Germany |
| Hunt, Stewart (InSphero 201602 General Manager at InSphero Inc) |
General Manager (management) |
InSphero (Group) |
United States (USA) |
| Hunter, Brian (Coral BioNet 201702 of BioNet Ventures) |
Managing Director |
Coral BioNet (Group) |
Germany |
| Huntsman, Peter R. (Huntsman 201710 CEO) |
n. a. |
Huntsman (Group) |
United States (USA) |
| Hurly, Stephen (Burrill 201307 CEO of Burrill Securities LLC) |
Chief Executive Officer (CEO) |
Burrill (Group) |
United States (USA) |
| Huser, Monique (Roche 200612) |
n. a. |
Roche (Group) |
Switzerland |
| Huss, Ralf (Definiens 201302– CMO + Apceth 201110– Development Manager before Roche) |
Research & Development Manager |
Apceth (Group) |
Germany |
| Husslein, Volker (GSK 201703 Head Communications at GSK Vaccines GmbH) |
Public Relations Manager / Investor Relations Manager |
GlaxoSmithKline (GSK) (Group) |
Germany |
| Hustert, Elisabeth (Scil) |
n. a. |
Coral BioNet (Group) |
Germany |
| Hutchinson, David B. A. (BioAgency 201102 Managing Director of Jomaa Pharma GmbH) |
Managing Director |
BioAgency AG |
Germany |
| Huth, Johannes (KKR 201506 Head KKR Europea, Afria + Middle East) |
President/Director/Head Business Group/Unit/Division |
Kohlberg Kravis Roberts (KKR) (Group) |
United States (USA) |
| Hutter, Bernd (Berthold Technologies 201107 Head Bioanalytical Instruments) |
President/Director/Head Business Group/Unit/Division |
Berthold Technologies (Group) |
Germany |
| Huxley, Alice (Speedel 200701 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Hušman, Dejan (DenovoMatrix 201902 Managing Director) |
Managing Director |
DenovoMatrix GmbH |
Germany |
| Hübler, Karl (Eucodis Bioscience GmbH 201604 CEO) |
Chief Executive Officer (CEO) |
Eucodis Bioscience (Group) |
Austria |
| Hübner, Marc (R-Biopharm 201605 Sales Manager Germany + Austria) |
Sales Manager / Marketing Manager |
R-Biopharm (Group) |
Germany |
| Hübschmann, Hans-Joachim (CTC Analytics 201511 VP Sales Asia before Thermo Fisher) |
Technical Manager |
CTC Analytics AG |
Japan |
| Hüls, Christoph (Merck KGaA 200808– VP Operational Excellence Research before Protagen CEO) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Hyman, Anthony (Max Planck 201901 Group Leader at MPI-CBG Dresden + Co-Founder Dewpoint Therapeutics) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Hüppe, Paul (Rehberg Hüppe + Partner 201409 Patent Attorney) |
Patent Attorney |
Rehberg Hüppe + Partner Patentanwälte PartG mbB (RHP) |
Germany |
| Hüttl, Reinhard F. (acatech 201002 + Member BioÖkonomieRat) |
Professor |
acatech – Deutsche Akademie der Technikwissenschaften |
Germany |
| Hüttner, Steffen (Hölle & Hüttner 200807 Managing Director) |
Managing Director |
HB Technologies (Group) |
Germany |
| Häckel, Marko (Neoplas GmbH 201206 Managing Director) |
Managing Director |
Neoplas GmbH |
Germany |
| Hämmerle, Hugo (Univ Tübingen 201204 Prof + Head of NMI) |
Researcher (university / research institute) |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Hänggi, Rolf (200808 before Roche VP) |
n. a. |
Roche (Group) |
Switzerland |
| Häßner, Tobias (Tecan Deutschland 200809) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Germany |
| Höfer, Constance (Priaxon 201401– Chief Development Officer before Medigene + Merck KGaA + Solvay) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Priaxon AG |
Germany |
| Höfgen, Norbert (DyNAbind GmbH 201705– Managing Director (COO) + Co-Founder) |
Managing Director |
DyNAbind GmbH |
Germany |
| Höfler, Gerald (Medical Univ Graz 201308 Professor at Institute for Pathology) |
Professor |
Medical University Graz |
Austria |
| Höger, Thomas (Apogenix 200511– CEO + CFO before since 10/00 DZ Bank before BASF/Knoll) |
Chief Executive Officer (CEO) |
Apogenix GmbH |
Germany |
| Höhling, Axel (ANiMOX GmbH 200810 Managing Director) |
Managing Director |
Animox GmbH |
Germany |
| Höppner, Oliver (KeyNeurotek 200305– before interim management for biotchs + GenProfile AG + Noxxon) |
n. a. |
KeyNeurotek (Group) |
Germany |
| Iann, Max Markus (Iann 2012– Founder) |
Investment Manager |
Iann (Group) |
Germany |
| Iannone, Lucio (Bayer 201904 at Leaps by Bayer) |
Investment Manager |
Bayer (Group) |
|
| Icheln, Bärbel (Peptrotech GmbH 200705) |
n. a. |
PeproTech (Group) |
Germany |
| Ietsugu, Hisashi (Sysmex 200602 CEO) |
Chief Executive Officer (CEO) |
Sysmex (Group) |
Japan |
| Ikeura, Yoshinori (Axcelead 201810 CEO) |
Chief Executive Officer (CEO) |
Axcelead Drug Discovery Partners Inc. (JP) |
Japan |
| Illek, Elmar (Bruker 201407 SVP Bruker Daltonics Commercial Operations before Thermo Fisher) |
Chief Commercial Officer (CCO) |
Bruker Corporation (Group) |
Germany |
| Imhof, Axel (LMU München 201504 Professor) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München) |
Germany |
| Imhof, René (Roche 200512) |
n. a. |
Roche (Group) |
Switzerland |
| Imhoff, Johannes F. (Leibniz-Gemeinschaft 201106 Professor + Head KiWiZ at IFM-GEOMAR) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| In-Albon, Beat (Lonza 201206– COO Life Science Ingredients sector before SGS 2006–2012 before Lonza) |
Chief Operating Officer (COO) |
Lonza Group (Group) |
Switzerland |
| Incerti, Carlo (Forbion 201901– Operating Partner before Sanofi Genzyme + Genzyme + Biofil Srl) |
Partner (venture partner) |
Forbion Capital Partners (NL) |
Netherlands |
| Ingendoh, Arnd (Bruker Daltonics 200905 VP European Life Science Sales) |
Sales Manager / Marketing Manager |
Bruker Corporation (Group) |
United States (USA) |
| Ingram, Douglas S. (Doug) (Sarepta Therapeutics 201902 CEO) |
Chief Executive Officer (CEO) |
Sarepta Therapeutics Inc. (NASDAQ: SRPT) |
United States (USA) |
| Irvine, Alistair (Kuros 201508 CBO) |
Chief Business Officer (CBO) |
Kuros (Group) |
Switzerland |
| Iseli, Bernhard (Tecan –200803) |
n. a. |
Tecan (Group) |
Switzerland |
| Ishida, Noriaki (Daiichi Sankyo 201512 VP Corp Communications Dept) |
Public Relations Manager / Investor Relations Manager |
Daiichi Sankyo (Group) |
Japan |
| Islam, Khalid (Gentium 200912– CEO before Arpida 199907–200805 CEO) |
Chief Executive Officer (CEO) |
Jazz Pharmaceuticals (Group) |
Italy |
| Itescu, Silviu (Mesoblast 201109 CEO) |
Chief Executive Officer (CEO) |
Mesoblast Ltd. |
Australia |
| Itin, Alexander (JSC Valenta Pharmaceuticals 201309 CEO) |
Chief Executive Officer (CEO) |
JSC Valenta Pharmaceuticals |
Russian Federation |
| Itin, Christian (Autolus 201603– CEO before Cytos 201211–201601 + Micromet 1999–2012 CEO + Co-founder + Zyomyx Inc) |
Chief Executive Officer (CEO) |
Autolus Therapeutics plc (Nasdaq: AUTL) |
United Kingdom (GB) |
| Ivanov, Igor (OncoLead 201012 Managing Director) |
Managing Director |
OncoLead (Group) |
Germany |
| Ivarrson, Mattias (Inositec 201610 CEO) |
Chief Executive Officer (CEO) |
Inositec AG |
Switzerland |
| Ivarsson, Carl-Johan (Qlucore AB 201209 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Qlucore AB |
Sweden |
| Iyer, Mohan (Second Genome 201503 CBO) |
Chief Business Officer (CBO) |
Second Genome Inc. |
United States (USA) |
| Jablonka, Bernd (Sanofi 201710 Strategy + Business Development, Public Private Partnership Sanofi Germany) |
Business Development Manager / Strategy Manager |
Sanofi (Group) [since May 2011] |
Germany |
| Jackson, Oliver (Peel Hunt 201707) |
n. a. |
Peel Hunt LLP |
United Kingdom (GB) |
| Jacobi, Philipp (Quadriga Capital 201811 Managing Partner) |
Managing Partner (investment firm) |
Quadriga Capital Eigenkapitalberatung GmbH |
|
| Jacobs, Elena M. (Eppendorf 201409) |
n. a. |
Eppendorf (Group) |
Germany |
| Jacotot, Frederic (Valneva 201704– General Counsel + Board Member joined 2013 before Abbott) |
General Counsel / Chief Legal Officer (CLO) |
Valneva (Group) |
France |
| Jaenichen, Hans-Rainer (Vossius & Partner 200809 Munich) |
n. a. |
Vossius & Partner patent attorneys |
Germany |
| Jaffrey, Samie (Weill Cornell Medicine 201810 Prof of Pharmacology + Co-Founder of Gotham Therapeutics) |
Professor |
Cornell University |
United States (USA) |
| Jafry, Syed (Thermo Fisher 201505 SVP + President Asia-Pacific + Emerging Markets) |
President/Director/Head Business Group/Unit/Division |
Thermo Fisher (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 25 26 27 ... 65 66 67 
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
